Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing.
Nucleic Acids Res
; 46(5): e25, 2018 03 16.
Article
in En
| MEDLINE
| ID: mdl-29237052
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tamoxifen
/
Transcriptional Activation
/
Estrogen Receptor beta
/
CRISPR-Cas Systems
/
Gene Editing
Limits:
Humans
Language:
En
Journal:
Nucleic Acids Res
Year:
2018
Document type:
Article
Affiliation country:
China
Country of publication:
United kingdom